title: Cefotaxime in the treatment of severe bacterial pneumonia in paediatric patients.
authors.affiliation: II Dept. University, Milan.
authors.forename: F
authors.initials: F
authors.lastname: Rusconi
authors.forename: L
authors.initials: L
authors.lastname: Rancilio
authors.forename: M A
authors.initials: MA
authors.lastname: Cerri
authors.forename: F
authors.initials: F
authors.lastname: Parizzi
authors.forename: M C
authors.initials: MC
authors.lastname: Pietrogrande
authors.forename: S
authors.initials: S
authors.lastname: Razon
authors.forename: P
authors.initials: P
authors.lastname: Rogari
authors.forename: L
authors.initials: L
authors.lastname: Serafini
authors.forename: G
authors.initials: G
authors.lastname: Torti
authors.forename: D
authors.initials: D
authors.lastname: Vaggi
mesh_terms: D000293:Adolescent; D002439:Cefotaxime / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D006192:Haemophilus Infections / Q000188:drug therapy; D006193:Haemophilus influenzae; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D011014:Pneumonia / Q000188:drug therapy* / Q000209:etiology; D011018:Pneumonia, Pneumococcal / Q000188:drug therapy; D013290:Streptococcal Infections / Q000188:drug therapy; D013297:Streptococcus pyogenes
chemical_list: D002439:Cefotaxime